Indefinite Delivery Contract 36E79721D0006
Award Date
3/15/21
Last Date to Order
3/14/22
Federal Agency
National Acquisition Center
Awardee
Seqirus USA Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Department of Veterans Affairs National Acquisition Center awarded an indefinite delivery contract to Seqirus USA Inc. to deliver influenza virus vaccines for the 2022-2023 season to the VA, Federal Bureau of Prisons, Indian Health Service, and James A. Lovell Federal Health Care Center. Task orders under the contract, with a potential value of $69,190,924.13, provide vaccines including 10-dose vials, single dose syringes in boxes of 10, and an adjuvant vaccine for individuals aged 65 and...
The IDV award provides Sanofi Pasteur Inc. with an IDIQ contract vehicle to supply influenza virus vaccines and related services to federal agencies through 2024. Task orders issued to date involve delivery of vaccines by the prime contractor to locations of the Department of Veterans Affairs, Bureau of Prisons, Indian Health Service, and other government customers. Performance spans multiple years at places including Swiftwater, PA, with total task order obligations approaching $80 million. The...
This single award IDV from the Department of Health and Human Services Centers for Disease Control and Prevention to Seqirus USA Inc. has a potential value of $129,537,700 to procure adult flu vaccines through February 2022. The originating solicitation sought to award one or more IDVs for the purchase of influenza vaccines for individuals aged 19 years and older, with a minimum order of 100 doses and maximum of 20 million doses to support adult immunization programs under Section 317(j) of...
The federal contract IDV award to Sanofi Pasteur Inc. is for the provision of influenza virus vaccines and related medical supplies to support various U.S. government agencies, including the Department of Veterans Affairs, Indian Health Service, Centers for Disease Control and Prevention, Defense Logistics Agency, Department of Health and Human Services, Department of Justice Bureau of Prisons, Smithsonian Institution, and Department of State. The 5-year single-award IDV, valued at up to...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency's Medical Supply Chain unit to Seqirus USA Inc., a global biotechnology company specializing in influenza vaccine development and delivery. The contract, valued at $36,120,112.50, aims to procure approximately 3.23 million doses of injectable influenza virus vaccines in multi-dose vials and pre-filled syringes for various age groups, including elderly, adult, and pediatric populations. The vaccines are intended...
The federal contract IDV being summarized is a multiple award Indefinite Delivery Contract (IDC) awarded by the Centers for Disease Control and Prevention (CDC) to Seqirus USA Inc. for the delivery of adult influenza vaccines for the 2024-2025 flu season. The $215,741,000 IDC covers a range of influenza vaccine products and presentations, including multi-dose vials, pre-filled syringes, and specialized formulations for different age groups. Seqirus, a foreign-owned for-profit manufacturer,...
This indefinite delivery contract issued by the Department of Veterans Affairs National Acquisition Center aims to procure influenza virus vaccines for the 2020-2021 season to support the Department of Veterans Affairs, Federal Bureau of Prisons, Indian Health Service, and James A. Lovell Federal Health Care Center. The original pre-solicitation notice sought quadrivalent influenza virus vaccines in multiple dose vials and pre-filled single dose syringes for individuals over 18 years of age,...
This IDV contract, awarded by the Defense Logistics Agency Troop Support, is for the supply of approximately 3.35 million doses of injectable influenza vaccine for the 2025-2026 flu season. The contract is a single-award indefinite quantity vehicle with a ceiling value of $25,058,634.80 and a period of performance through February 13, 2026. The prime contractor is Sanofi Pasteur Inc., a foreign-owned, for-profit pharmaceutical manufacturer specializing in vaccines and medical supplies. The...
This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) to Seqirus USA Inc., a global biotechnology company specializing in influenza vaccine development and delivery. The $143 million IDC is for the supply of adult influenza vaccines, and a separate $208 million IDC is for pediatric influenza vaccines, to support the CDC's nationwide immunization programs from 2022-2023. Seqirus USA Inc. has also been awarded several other high-value...
The Defense Logistics Agency Troop Support Medical awarded a single-award Indefinite Delivery Contract to Seqirus USA Inc. with a potential value of $12,954,518.10 to supply influenza virus vaccinations. Under this contract, three firm fixed price delivery orders have been issued to Seqirus USA Inc. totaling $12,710,418.40 to provide influenza virus vaccinations for the 2022-2023 flu season. The delivery orders require vaccinations be delivered to Summit, New Jersey by August 31, 2022. The...
Name | Description | Awardee | Potential Value (Click to sort descending) | Award Date (Click to sort descending) | Completion Date (Click to sort descending) | Updated At (Click to sort descending) |
|---|---|---|---|---|---|---|
Delivery Order 36E79721D0006-15B11121FWM430008 | Seqirus USA Inc. | $1.3k | 3/26/21 | 9/17/21 | 3/26/21 | |
Delivery Order 36E79721D0006-15B40321FWB110060 | Seqirus USA Inc. | $6.4k | 4/15/21 | 10/15/21 | 4/15/21 | |
Delivery Order 36E79721D0006-15B31021FWB130165 | Seqirus USA Inc. | $5.1k | 3/15/21 | 8/15/21 | 3/15/21 | |
Delivery Order 36E79721D0006-15BH0N21FWB110016 | Seqirus USA Inc. | $4.2k | 3/30/21 | 9/30/21 | 3/30/21 | |
Delivery Order 36E79721D0006-36C24521N0349 | Seqirus USA Inc. | $180.2k | 3/31/21 | 12/31/21 | 3/30/21 |